Related Experiment Video
Updated: Aug 15, 2026
11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
[Breast-conserving therapy in breast cancer]
Anne Marcollet1, Virginie Doridot, Claude Nos
1Service de chirurgie générale et sénoloqique, Institut Curie, 26 rue d'Ulm, 75005 Paris. anne.marcollet@curie.net
La Revue Du Praticien
|July 28, 2004
Summary
Breast-conserving therapy, combining lumpectomy, axillary node treatment, and radiotherapy, is a standard option for early-stage breast cancer. Advances like neoadjuvant therapies and surgical techniques expand its applicability and improve outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Context:
- Breast-conserving therapy (BCT) is a cornerstone treatment for early-stage breast cancer.
- Mammography advancements have increased the detection of subclinical breast carcinomas, favoring BCT.
- Standard BCT indications are evolving with new therapeutic strategies.
Purpose:
- To outline the current standards and evolving landscape of breast-conserving therapy.
- To discuss factors influencing the selection and success of BCT.
- To highlight the importance of oncologic management and margin evaluation in BCT.
Summary:
- Breast-conserving therapy involves lumpectomy, axillary node treatment, and radiotherapy, suitable for unifocal, non-inflammatory lesions <3 cm.
- Neoadjuvant therapies (chemotherapy, radiotherapy, hormonotherapy) and techniques like sentinel node biopsy and oncoplastic surgery broaden BCT indications.
- Optimizing oncologic management requires careful evaluation of local recurrence risk and surgical margins.
Impact:
- BCT offers a standard, effective treatment option for a growing number of breast cancer patients.
- Minimally invasive techniques and oncoplastic surgery improve cosmetic outcomes alongside oncologic control.
- Continued research and technique refinement enhance the efficacy and applicability of breast-conserving breast cancer treatments.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...